Verdict
The Searle Company Limited opened FY2027 with a strong consolidated earnings result. For the quarter ended September 30, 2026, revenue grew 15.2%, gross profit rose 22.0%, and profit attributable to shareholders increased 26.9%. Gross margin expanded by 3.16 percentage points, while finance cost was nearly contained. The result shows a clear operating recovery.
The quality of that growth is not uniformly strong, however. Operating cash flow reversed from a PKR 219 million inflow to a PKR 2.76 billion outflow. Trade receivables increased 25.4% in only three months, trade payables declined 16.8%, cash balances fell, and short-term borrowings rose. The earnings statement is improving faster than cash conversion.
This is therefore a positive quarter with an important qualification: profitability strengthened, but more cash became tied up in the operating cycle. The abbreviated result does not provide a product, volume, pricing, geography or input-cost bridge, so the article explains the verified financial transmission without attributing the improvement to an undisclosed company-specific cause.
Reporting basis
The primary analysis uses the unaudited consolidated statements for the three months ended September 30, 2026, compared with the same quarter of 2025. Figures are in Pakistani rupees; the filing tables are presented in PKR thousand. The balance sheet compares September 30, 2026 with the audited June 30, 2026 year-end. The filing also provides unconsolidated statements, but consolidated figures better represent the group and reconcile with the current AlphaGen period.
Comparative earnings per share is explicitly marked as restated. Paid-up capital at September 2026 was PKR 5.88 billion compared with PKR 5.12 billion a year earlier, so the restated EPS should be used rather than dividing the prior reported profit by the old share count.
Results at a glance
- Consolidated revenue: PKR 11.18 billion, up 15.2% from PKR 9.70 billion.
- Gross profit: PKR 6.40 billion, up 22.0%; gross margin improved to 57.23% from 54.08%.
- Profit from operations: PKR 2.23 billion, up 22.3%; operating margin rose to 19.96% from 18.80%.
- Profit before income tax after levies: PKR 1.93 billion, up 27.3%.
- Consolidated profit for the period: PKR 1.20 billion, up 30.8%.
- Profit attributable to shareholders: PKR 1.15 billion, up 26.9%; restated EPS increased to PKR 1.95 from PKR 1.54.
- Net operating cash flow: negative PKR 2.76 billion, versus positive PKR 219 million.
- The board announced no cash dividend, bonus shares or rights issue with this result.
What improved
Revenue increased by PKR 1.48 billion, while cost of sales rose by only PKR 326 million. That difference added PKR 1.15 billion to gross profit, which reached PKR 6.40 billion. Gross margin improved to 57.23% from 54.08%, a 3.16 percentage-point expansion.
This is the main driver of the quarter. The filing does not disclose whether the margin improvement came from price increases, product mix, higher volumes, manufacturing utilization, raw-material costs, foreign exchange or a combination of factors. The defensible conclusion is narrower: the cost of sales grew materially slower than revenue, allowing more of each sales rupee to remain as gross profit.
The gross-profit gain was large enough to absorb substantially higher selling and administrative costs. Distribution costs increased 16.3% to PKR 3.31 billion, administrative expenses rose 41.9% to PKR 699 million, and other operating expenses increased 67.9% to PKR 210 million. Other income rose to PKR 50 million but remained too small to drive the result.
Combined distribution, administration and other operating expense, net of other income, increased by about PKR 745 million. Gross profit increased by about PKR 1.15 billion. The remaining PKR 407 million flowed into profit from operations, which rose 22.3% to PKR 2.23 billion. Operating margin consequently improved by 1.16 percentage points to 19.96%.
Below operating profit, finance cost increased only 3.1% to PKR 297 million, far slower than revenue or operating profit. Levies classified as minimum and final tax declined to PKR 5 million from PKR 20 million. Profit before income tax therefore increased 27.3% to PKR 1.93 billion.
Tax expense increased 21.9% to PKR 732 million, but the effective income-tax rate eased to approximately 38.0% from 39.7%. Consolidated profit grew 30.8% to PKR 1.20 billion. Non-controlling interests received PKR 50 million, leaving PKR 1.15 billion attributable to owners of the holding company.
What weakened / needs attention
Operating expenses grew quickly. Distribution costs remain the largest expense after cost of sales and consumed 29.6% of revenue, slightly above the prior-period ratio. Administrative expense rose to 6.25% of revenue from 5.08%, while other operating expense increased to 1.88% from 1.29%. The company still expanded operating margin, but only because gross-margin improvement outweighed this overhead growth.
Cash conversion weakened materially. Cash generated from operations before finance cost, tax and other listed payments was already negative PKR 2.19 billion, compared with positive PKR 668 million a year earlier. After finance cost, income tax, employee benefits, deposits and lease rentals, net operating cash flow was negative PKR 2.76 billion versus positive PKR 219 million.
The quarter-end balance sheet provides a coherent explanation, although the brief filing does not include the detailed working-capital note. Trade receivables increased by PKR 3.13 billion, or 25.4%, to PKR 15.48 billion between June and September. Trade and other payables fell by PKR 1.44 billion, or 16.8%, to PKR 7.15 billion. Inventories decreased by PKR 479 million to PKR 7.05 billion, which released some cash but was not enough to offset the receivable build and lower supplier funding.
Receivables represented about half of current assets at September 2026. That makes collection speed, channel inventory and credit discipline central to the next quarter’s cash outcome. The filing does not disclose customer aging, collection timing or the product and geography responsible for the increase, so it would be speculative to assign the movement to one business line.
Balance sheet, debt and liquidity
Current assets rose 2.4% to PKR 30.59 billion, while current liabilities fell 3.1% to PKR 16.37 billion. Reported working capital therefore improved to PKR 14.22 billion from PKR 12.98 billion, and the current ratio increased to about 1.87 times from 1.77 times. Excluding inventories, the quick ratio improved to roughly 1.44 times from 1.32 times.
Those headline liquidity ratios look comfortable, but the composition became less cash-rich. Cash and bank balances fell 39.4% to PKR 1.50 billion. Short-term investments declined to PKR 254 million from PKR 400 million, while trade receivables rose sharply. Liquidity became more dependent on collecting customer balances.
Borrowing also increased. Short-term borrowings rose 12.4% to PKR 8.83 billion, while long-term borrowings declined slightly to PKR 116 million. Gross borrowings were about PKR 8.94 billion at September, compared with PKR 7.98 billion in June. After subtracting cash, net debt increased to approximately PKR 7.44 billion from PKR 5.51 billion.
The cash-flow statement shows how that funding entered the business. Financing activities generated PKR 1.92 billion, mainly because PKR 2.25 billion was raised through short-term Islamic finance, partly offset by a PKR 327 million running-musharaka repayment. Investing activities produced a PKR 419 million inflow, helped by PKR 650 million of proceeds against disposal of subsidiary companies. Capital expenditure increased to PKR 269 million from PKR 98 million.
Even after those financing and disposal inflows, cash and cash equivalents fell by PKR 425 million during the quarter to PKR 1.15 billion. This cash-equivalent figure differs from the PKR 1.50 billion cash-and-bank balance because the filing references a separate cash-equivalents note that is not included in the nine-page announcement. The two figures should not be treated as identical.
Historical context
Searle’s recent history has been volatile. The company’s FY2026 consolidated revenue was materially above earlier years, but profitability was distorted by a weak June quarter and a large tax charge. The September 2026 quarter’s PKR 1.20 billion consolidated profit is more than twice the approximately PKR 536 million reported for the entire preceding fiscal year. That comparison demonstrates the scale of the rebound, but it should not be annualized mechanically because the prior year contained unusual quarterly volatility.
Longer-run profitability has also moved through a broad cycle. Consolidated operating margin was above 20% in FY2021, fell into the low-to-mid teens in subsequent years, and recovered toward 16% in FY2026. The current quarter’s 19.96% operating margin is therefore encouraging, but one quarter does not yet establish a structural return to the earlier peak.
The group manufactures and markets pharmaceutical and consumer-health products through a multi-entity structure. The consolidated presentation includes non-controlling interests and investment properties, while the parent-only statements exclude subsidiary activity. This is why mixing consolidated revenue with unconsolidated profit or balance-sheet figures would produce misleading comparisons.
AlphaGen model scores
The following are AlphaGen model outputs, not figures reported by Searle and not investment recommendations:
- Alpha QoQ Score: 94.88
- TTM Performance Score: 89.72
- 3Y Business Perf Score: 70.36
- Sector Leadership Score: 82.00
The high quarterly and TTM scores align with the strong earnings recovery and wider margins. The lower, though still positive, three-year score reflects a less consistent multi-year record. The sector-leadership score indicates strong relative operating performance, but the model readings do not remove the need to monitor cash conversion and leverage.
What to monitor next
- The split of revenue growth between volumes, pricing, product mix, exports and subsidiary contributions.
- Whether gross margin remains above 57% without a reversal in input costs or mix.
- Trade-receivable collections after the PKR 3.13 billion increase during the quarter.
- A recovery in operating cash flow from the PKR 2.76 billion outflow.
- Short-term borrowings and finance cost after the PKR 2.25 billion Islamic-finance inflow.
- The continuing cost base, particularly administrative and other operating expenses.
- Further disclosure on the PKR 650 million subsidiary-disposal proceeds and any recurring earnings implications.
Evidence limitations
This is a pass with disclosed limitations. The official filing verifies the consolidated earnings, balance sheet, cash flow, EPS basis and lack of a payout announcement. It does not include detailed notes, management commentary, brand or therapeutic-area sales, volumes, pricing, geography, raw-material costs, foreign-exchange effects, receivable aging or a working-capital reconciliation. The article therefore omits unsupported causal claims and focuses on the arithmetic transmission visible in the statements.
Primary sources
PSX: SEARL financial results for the quarter ended September 30, 2026
PSX company page: The Searle Company Limited
The Searle Company: investor information and financial reports